
Articles
-
1 week ago |
genengnews.com | Uduak Grace Thomas
Home Topics Cancer Bypassing Size Constraints, Scientists Use CD36 Protein to Deliver Bulky PROTACs Proteasome collaborate with ubiquitin to degrade proteins. [Love Employee/Getty Images] Proteasome collaborate with ubiquitin to degrade proteins.
-
1 week ago |
genengnews.com | Uduak Grace Thomas
Scientists from Cincinnati Children’s Hospital Medical Center and their collaborators have used human stem cells to develop liver organoids that faithfully replicate key zones observed in human livers. Furthermore, when the organoids were transplanted into immunodeficient rats whose liver-bile duct systems had been disconnected, their survival rates nearly doubled.
-
1 week ago |
genengnews.com | Uduak Grace Thomas
Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, that will allow it to expand into the Asia-Pacific region. The partners aim to industrialize what they claim will be the first clinical-stage autologous induced pluripotent stem cell-derived (iPSC) therapy for peripheral artery disease and coronary artery disease.
-
1 week ago |
genengnews.com | Corinna Singleman |Alex Philippidis |Uduak Grace Thomas |Fay Y. Lin
Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.
-
2 weeks ago |
genengnews.com | Uduak Grace Thomas
Scientists from the University of Cambridge and their collaborators have developed an algorithm that identifies unique patterns caused by insertions and deletions in tumor DNA.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →